GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
1.3k
c/glp1eu·posted 1 year ago by u/hydration_hank

three years of Apotheke threads, summarised so you do not have to read them

Country Sourced ×2 Slow Clap ×1

three years of Apotheke threads, summarised so you do not have to read them, which sounds obvious until you try to state the evidence for it.

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.

1,488 up / 211 down88% upvoted44 commentsid 1vil7y4 Sep 2024

44 comments

30 in this archive, depth 4

best — the order this archive was captured in

u/renal_outcomes_rnephro-curious0 points·1 year ago

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/mikkel_correia0 points·1 year ago

Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.

replysharereportpermalink
u/marisol_frisk1 point·1 year ago

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/ignacio_vanhecke1 point·1 year ago

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/hydration_hankOP1 point·1 year ago

ask for the Beipackzettel or the local equivalent, it answers most questions

replysharereportpermalink
u/mei_cardoso1 point·1 year ago

the same product has different names and pack sizes across the union

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink
u/signe_villalobos1 point·1 year ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/tobias_vukovic144 points·1 year ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

replysharereportpermalink
u/hydration_hankOP87 points·1 year ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/nayeli_fonseca22 points·1 year ago

say which country or the thread is useless

replysharereportpermalink
u/camila_marchand43 points·1 year ago

cross-border prescription rules exist and they are narrower than people think

replysharereportpermalink
u/arne_ndiaye30 points·1 year ago

cross-border prescription rules exist and they are narrower than people think

camila_marchand is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/ahmed_fonseca67 points·1 year ago

Cosigning on cross-border prescriptions. The rules exist and they are narrower than the summaries suggest.

replysharereportpermalink
u/greta_nilsen77 points·1 year ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

replysharereportpermalink
u/chidi_demir33 points·1 year ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink
u/still_here_202662 points·1 year ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/fabio_nkemelu51 points·1 year ago

the language barrier is a real cost and nobody budgets for it

replysharereportpermalink
u/marisol_kravchenko66 points·1 year ago

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

replysharereportpermalink
u/wanjiru_ramos43 points·1 year ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/marisol_kravchenko-18 points·1 year ago

the EMA authorises, member states decide who pays

replysharereportpermalink
u/hydration_hank1 point·1 year ago

Same. Naming the country in the first line would fix most of the bad advice on this board.

replysharereportpermalink
u/erez_yilmaz1 point·1 year ago

That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.

replysharereportpermalink
u/ignacio_silva35 points·1 year ago

keep the prescription and the receipt, both matter for claims

replysharereportpermalink
u/diego_iyer14 points·1 year ago

Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.

replysharereportpermalink
u/hydration_hank27 points·1 year ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/naomi_erdogan54 points·1 year ago

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

replysharereportpermalink
u/joaquin_trevino34 points·1 year ago

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/noor_ivaturi27 points·1 year ago

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/rania_marchand9 points·1 year ago

the reimbursement criteria are published in most member states

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.